-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Downgrades Moderna to Sell, Raises Price Target to $80

Benzinga·09/30/2026 10:22:51
Listen to the news
Citigroup analyst Geoff Meacham downgrades Moderna (NASDAQ:MRNA) from Neutral to Sell and raises the price target from $60 to $80.